Antioxidant status and lipid peroxidation in sickle cell anaemia

Biomedical Research

Volumn 21, Issue 4, 2010, Pages 461-464

  Hundekar, Prakash ^a   Suryakar, Adinath ^b   Karnik, Aarti ^a   Ghone, Rahul ^a   Vasaikar, Maya ^b  

^a ACPM Medical College   (India)

^b Shri Bhausaheb Hire GMC ^*  (India)

Author keywords

Catalase; Malondialdehyde; Sickle cell anaemia; Superoxide dismutase; Total antioxidant capacity

Indexed keywords

ANTIOXIDANT; CATALASE; LIPID; MALONALDEHYDE; OXIDIZING AGENT; SUPEROXIDE DISMUTASE;

ARTICLE; CELL ACTIVITY; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ERYTHROCYTE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; OXIDATIVE STRESS; SICKLE CELL ANEMIA;

EID: 80051536248     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Diggs L. Anatomic lesions in sickle cell disease. In: Abramson H, Bertles J, Wethers D, eds. Sickle Cell Disease: Diagnosis, Management, Education and Research. St. Louis: CV Mosby; 1973:189-229.
2. Kate SL 2001. Health problems of tribal population groups from state of Maharashtra. Ind J Med Sci.2001; 5(2): 99-108.
3. Serjeant GR. Sickle Cell Disease. Lancet. 1997; 350: 725-730.
4. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997; 337: 762-769.
5. Hebbel RP, Eaton IW, Balasingam M, Steinberg MH. Spontaneous oxygen radical generation by sickle eryth-rocytes. J Clin Invest. 1982; 70: 1253-1259.
6. Carrell RW, Winterbourn CC, Rachmilewitz EA: Activated oxygen and hemolysis. Br J Haematol. 1975; 30: 259-264.
7. Wilson JB, Headlee ME, Huisman TH. A new high performance liquid chromatographic procedure for the separation and quantification of various haemoblobin variants in adults and newborn babies. J Lab Clin Med. 1983; 102: 174-186.
8. Satho's K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chem Acta. 1978; 90: 37-43.
9. Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996; 239:70-76.
10. Rosemary E. Hawkins et al. The estimation of red cell superoxide dismutase activity. J lab Clin Med. 1975; 185: 337-341.
11. Vitai M, Goth L. Reference ranges of normal blood catalase activity and levels in familial hypocatalasemia in Hungary. Clin Chim Acta.1997; 261:35-42.
12. Chan AC, Chow CK, Chiu D. Interaction of Antioxidants and Their Implication in Genetic Anaemia. Proc Soc Exp Biol Med. 1999; 222: 274-282.
13. Titus J, Chari S, Gupta M, Parekh N. Pro-oxidant and anti-oxidant status in patients of sickle cell anaemia. Ind J Clin Biochem. 2004; 19 (2): 168-172.
14. Das SK, Nair R: Superoxide dismutase, glutathione peroxidase, catalase and lipid peroxidation of normal and sickled erythrocytes. Br J Haematol 1980;44:87-91.
15. Jain SK. The accumulation of malonyldialdehyde, a product of fatty acid peroxidation, can disturb amino-phospholipid organization in the membrane bilayer of human erythrocytes. J Biol Chem.1984; 259:3391-3394.
16. Chiu D, Lubin B, Shohet SB. Peroxidative reactions in red cell biology. In: Pryor W, ed. Free Radicals in Biology. New York: Academic Press; 1982:115-160.
17. Capo C, Bongrand P. Benoliel AM, Depieds R: Non-specific recognition in phagocytosis: Ingestion of alde-hyde-treated erythrocytes by rat peritoneal macro-phages. Immunology 1979; 36:501-508.
18. Sears DA, Friedman JM, White DR. Binding of protein to the erythrocyte membrane during incubation: the production of Heinz bodies. J Lab Clin Med 1975; 86: 722-732.
19. Arinola OG, Olaniyisa SA, Akibinu MO. Evaluation of antioxidant levels and trace elements status in Nigerian sickle cell disease patients with plasmodium parasitaemia. Pak J. Nut.2008; 7(6): 766-769.
20. Foluke F, Kayode A, Johan A, Modupe K. Total anti-oxidant status in sickle cell disease patients in steady state. J. Nat. Med. Asso. 2008; 100 (8): 891-894.
21. Chiu D, Lubin B. Abnormal vitamin E and glutathione peroxidase levels in sickle cell anemia: evidence for increased susceptibility to lipid peroxidation in vivo. J Lab Clin Med. 1979; 94:542-548.
22. Jain SK, Ross JD, Duett J, et al. Low plasma prealbumin and carotenoid levels in sickle cell disease patients. Am J Med Sci. 1990; 299: 13-15.
23. Adelekan DA, Thurnham DI, Adekile AD. Reduced antioxidant capacity in paediatric patients with homozygous sickle cell disease. Eur J Clin Nutr 1989; 43: 609-614.
24. Ananda P, Jesus O, George J. B, Donald O; Eric BS. Trace elements in sickle cell disease. JAMA 1976; 235: 2396-2398.
25. Hasanato R. Zinc and antioxidant vitamin deficiency in patients with severe sickle cell anaemia. Ann Saudi Med 2006; 26 (1):17-21.